LI Yan-qiu,LI Jian-chun,GUAN Hong-quan,CAI Yu-wen.Changes of IL-18 and Th1/Th2 in serum of lung cancer patients and their relationship with tumor staging[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(08):731-732.
LI Yan-qiu,LI Jian-chun,GUAN Hong-quan,CAI Yu-wen.Changes of IL-18 and Th1/Th2 in serum of lung cancer patients and their relationship with tumor staging[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(08):731-732.DOI:
IL-10) in patients with lung cancer and their relation to clinical pathological stages. Methods Totally 109 lung cancer patients were of 45 squamous cancer
40 adenocarcinoma
18 small cell lung cancer and 6 large cell carcinoma. Serum levels of IL-18
TNF-α
IL-2
IL-4 and IL-10 were determined by using an ELISA assay in 109 lung cancer patients and in 30 normal people. Results The levels of IL-18
TNF-α and IL-2 were significantly lower and the levels of IL-4 and IL-10 were significantly higher in lung cancer patients than in controls (P0.05). The level of IL-18 in small cell lung cancer was lower than that in other kinds of lung cancer(P0.01). With progress of the clinical pathological stages
serum levels of IL-18
IL-2 and TNF-α decreased accordingly. Conclusion Serum levels of IL-18 and Th1/Th2 subsets may be related to immune functions of lung cancer patients and be a good sign of prognosis.